Jefferies Financial Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,156
Closed -$1.01M 2129
2025
Q4
$1.01M Buy
+6,156
New +$964K 0.01% 1078
2025
Q3
Sell
-14,280
Closed -$1.78M 1640
2025
Q2
$1.78M Buy
14,280
+8,247
+137% +$1.05M 0.01% 561
2025
Q1
$768K Buy
+6,033
New +$929K 0.01% 906
2024
Q4
Sell
-6,888
Closed -$1.03M 1804
2024
Q3
$1.03M Buy
6,888
+1,600
+30% +$229K 0.01% 776
2024
Q2
$667K Buy
5,288
+3,205
+154% +$502K 0.01% 874
2024
Q1
$383K Buy
+2,083
New +$397K ﹤0.01% 1133
2023
Q4
Sell
-5,773
Closed -$899K 1941
2023
Q3
$918K Sell
5,773
-3,305
-36% -$540K 0.01% 858
2023
Q2
$1.28M Buy
+9,078
New +$1.46M 0.01% 824

Other funds holding RGEN

Jefferies Financial Group's RGEN Position: Q1 2026 in Review

Jefferies Financial Group sold out of Repligen (RGEN) in Q1 2026, closing a stake of 6,156 shares — an estimated $1.01M sold.

Jefferies Financial Group first reported a position in RGEN in Q2 2023 and held it in 8 quarters. The position peaked at $1.78M in Q2 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Jefferies Financial Group reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 6,156 Repligen shares in Q1 2026, an estimated $1.01M.
  • Jefferies Financial Group first reported a position in Repligen in Q2 2023 and held it in 8 quarters.
  • Jefferies Financial Group's Repligen position peaked at $1.78M in Q2 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.